交泰丸最初是一个治疗失眠、怔忡的丸方,随着现代药理和临床应用的不断研究,交泰丸的作用机制和适用范围不断发展。近两年,从肠道菌群、炎症等方面,对交泰丸、失眠、糖尿病等的研究取得了新的进展。本文结合最新进展,通过系统整理近年有关交泰丸的相关文献资料,从化学组成、药理作用、临床应用和医理创新等方面阐述交泰丸的研究进展,为交泰丸的临床应用和实验研究提供参考。Jiaotai Pill was originally a pill prescription for the treatment of insomnia and palpitation, but with the continuous study of modern pharmacology and clinical application, the action mechanism and scope of application of Jiaotai Pill are constantly developing. In the past two years, significant progress has been made in the research of Jiaotai pills, insomnia, diabetes, and other related areas such as intestinal flora and inflammation. This paper systematically collates recent literature on Jiaotai pill and expounds on its research progress in terms of chemical composition, pharmacological action, clinical application, and medical innovation. The aim is to provide a reference for the clinical application and experimental research of Jiaotai pill based on the latest advancements.
目的通过网络药理学和分子对接技术对交泰丸治疗失眠的作用机制进行研究。方法交泰丸活性成分由中药系统药理学数据库与分析平台(Traditional Chinese Medicine Systems Pharmacology Database andAnalysis Platform,TCMSP)、中医药整合药理学研究平台(Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine,TCMIP)整合获得,SwissTargetPrediction数据库预测作用靶点,整合DisGeNET、DrugBank疾病基因数据库中失眠的靶点基因。采用Venny 2.1在线软件作图工具平台,获取活性成分与失眠靶点的交集靶,Cytoscape 3.9.1作图软件构建交泰丸活性成分的交集靶点网络,分析得到交泰丸核心成分。蛋白互作网络、核心靶点由STRING12.0数据库获得,DAVID数据进行基因本体(gene ontology,GO)功能注释和京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)通路富集分析,采用AutoDockTools1.5.7 Pymol软件对关键靶点与成分进行分子对接、可视化处理。结果筛选得到交泰丸中治疗失眠的5个核心成分依次为小檗碱、柠檬苦素、黄柏酮、N-反式阿魏酰酪胺、黄藤素,筛选出5-羟色胺(5-hydroxy tryptamine,5-HT)转运体(solute carrier family 6 member,SLC6A4)、多巴胺受体(dopamine receptor D2,DRD2)、烟碱乙酰胆碱受体(cholinergic receptor nicotinic alpha 4 subunit,CHRNA4)、肿瘤坏死因子(tumor necrosis factor,TNF)、前列腺素内过氧化物合酶(prostaglandin-endoperoxide synthase 2,PTGS2)等核心靶点。交泰丸治疗失眠的信号通路主要富集于调节5-HT能突触、多巴胺能突触等。分子对接显示核心成分小檗碱、柠檬苦素、黄柏酮等与核心靶点SLC6A4、DRD2、CHRNA4、TNF、PTGS2等对接程度良好。结论交泰丸中小檗碱、柠檬苦酸、黄柏酮等成分通过影响SLC6A4、DRD2、TNF、CHRNA4、PTGS2等蛋白的表达,多作用机制治疗失眠。
